Carense Ltd 12378533 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is Wholesale of chemical products, wholesale of pharmaceutical goods, other manufacturing not elsewhere classified Digita Accounts Production Advanced 6.30.9574.0 true true 12378533 2023-01-01 2023-12-31 12378533 2023-12-31 12378533 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2023-12-31 12378533 core:RetainedEarningsAccumulatedLosses 2023-12-31 12378533 core:ShareCapital 2023-12-31 12378533 core:CurrentFinancialInstruments 2023-12-31 12378533 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 12378533 core:Non-currentFinancialInstruments 2023-12-31 12378533 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 12378533 core:FurnitureFittingsToolsEquipment 2023-12-31 12378533 bus:SmallEntities 2023-01-01 2023-12-31 12378533 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 12378533 bus:FilletedAccounts 2023-01-01 2023-12-31 12378533 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 12378533 bus:RegisteredOffice 2023-01-01 2023-12-31 12378533 bus:Director1 2023-01-01 2023-12-31 12378533 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2023-01-01 2023-12-31 12378533 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12378533 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 12378533 core:OfficeEquipment 2023-01-01 2023-12-31 12378533 countries:EnglandWales 2023-01-01 2023-12-31 12378533 2022-12-31 12378533 core:FurnitureFittingsToolsEquipment 2022-12-31 12378533 2022-01-01 2022-12-31 12378533 2022-12-31 12378533 bus:OrdinaryShareClass1 bus:CumulativeNon-redeemableShares 2022-12-31 12378533 core:RetainedEarningsAccumulatedLosses 2022-12-31 12378533 core:ShareCapital 2022-12-31 12378533 core:CurrentFinancialInstruments 2022-12-31 12378533 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 12378533 core:Non-currentFinancialInstruments 2022-12-31 12378533 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 12378533 core:FurnitureFittingsToolsEquipment 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12378533

Carense Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2023

 

Carense Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 9

 

Carense Ltd

Company Information

Director

Mr Ahmad Baden

Registered office

71-75 Shelton Street
Covent Garden
London
Greater London
WC2H 9JQ

Accountants

The Moffatts Partnership LLP
Suite 1.1, First Floor
Jackson House
Sibson Road
Sale
M33 7RR

 

Carense Ltd

(Registration number: 12378533)
Balance Sheet as at 31 December 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

246

367

Current assets

 

Stocks

5

5,039

1,639

Debtors

6

1,171

365

Cash at bank and in hand

 

1,033

8,069

 

7,243

10,073

Creditors: Amounts falling due within one year

7

(20,516)

(7,802)

Net current (liabilities)/assets

 

(13,273)

2,271

Total assets less current liabilities

 

(13,027)

2,638

Creditors: Amounts falling due after more than one year

7

-

(12,930)

Net liabilities

 

(13,027)

(10,292)

Capital and reserves

 

Called up share capital

8

1

1

Retained earnings

(13,028)

(10,293)

Shareholders' deficit

 

(13,027)

(10,292)

 

Carense Ltd

(Registration number: 12378533)
Balance Sheet as at 31 December 2023

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 19 September 2024
 

.........................................
Mr Ahmad Baden
Director

 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
71-75 Shelton Street
Covent Garden
London
Greater London
WC2H 9JQ
United Kingdom

These financial statements were authorised for issue by the director on 19 September 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The directors have a reasonable expectation that the company will have adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis on preparing its financial statements.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Government grants

Government grants are recognised under the accrual model. Income is recognised in the same period that the related expenditure the grant is intended to compensate is incurred.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

33% Reducing Balance Basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 January 2023

635

635

At 31 December 2023

635

635

Depreciation

At 1 January 2023

268

268

Charge for the year

121

121

At 31 December 2023

389

389

Carrying amount

At 31 December 2023

246

246

At 31 December 2022

367

367

5

Stocks

2023
£

2022
£

Other inventories

5,039

1,639

6

Debtors

2023
£

2022
£

Other debtors

1,171

365

1,171

365

 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

7

Creditors

Creditors: amounts falling due within one year

Note

2023
£

2022
£

Due within one year

 

Loans and borrowings

9

15,986

5,625

Accruals and deferred income

 

960

420

Other creditors

 

3,570

1,757

 

20,516

7,802

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

9

-

12,930

8

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary share class 1 of £1 each

1

1

1

1

       
 

Carense Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2023

9

Loans and borrowings

Non-current loans and borrowings

2023
£

2022
£

Bank borrowings

-

12,930

Current loans and borrowings

2023
£

2022
£

Bank borrowings

15,986

5,625